Compare HTGC & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HTGC | AXGN |
|---|---|---|
| Founded | 2003 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.6B |
| IPO Year | 2004 | 2013 |
| Metric | HTGC | AXGN |
|---|---|---|
| Price | $16.41 | $38.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 11 |
| Target Price | $19.50 | ★ $53.09 |
| AVG Volume (30 Days) | 1.0M | ★ 1.3M |
| Earning Date | 10-29-2026 | 10-28-2026 |
| Dividend Yield | ★ 11.46% | N/A |
| EPS Growth | ★ 14.91 | N/A |
| EPS | ★ 0.90 | N/A |
| Revenue | N/A | ★ $225,208,000.00 |
| Revenue This Year | $9.32 | $26.82 |
| Revenue Next Year | $7.07 | $28.63 |
| P/E Ratio | $18.19 | ★ N/A |
| Revenue Growth | N/A | ★ 20.21 |
| 52 Week Low | $13.70 | $17.14 |
| 52 Week High | $19.13 | $52.91 |
| Indicator | HTGC | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 44.57 | 46.51 |
| Support Level | $16.09 | $30.10 |
| Resistance Level | $17.05 | $39.99 |
| Average True Range (ATR) | 0.27 | 1.29 |
| MACD | 0.01 | 0.53 |
| Stochastic Oscillator | 58.61 | 86.41 |
Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. The company's primary business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments mainly in structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It finances companies belonging to computer software and hardware, networking systems, semiconductors, medical devices, bio-pharmaceutical, and other related sectors.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.